Can blood components with age-related changes influence the ageing of endothelial cells?

Experimental Dermatology

Volumn 19, Issue 4, 2010, Pages 339-346

  Noh, Ji Yeon ^a   Oh, Sang Ho ^a   Lee, Ju Hee ^a   Kwon, Yeon Sook ^a   Ryu, Dong Jin ^a   Lee, Kwang Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Ageing; Cytoskeletal regulator; Human dermal microvascular endothelial cells; Tumor suppressor

Indexed keywords

BINDING PROTEIN; COFILIN 1; GELSOLIN LIKE CAPPING PROTEIN; LIPOCORTIN 5; MESSENGER RNA; RAS PROTEIN; RAS SUPPRESSOR GENE PROTEIN 1; THIOREDOXIN DOMAIN CONTAINING 5 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BLOOD COMPONENT; CELL AGING; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SENESCENCE; SIGNAL TRANSDUCTION; SKIN BLOOD VESSEL;

ACTINS; ADULT; AGED; AGING; ANNEXIN A5; BLOTTING, WESTERN; CELL AGING; COFILIN 1; DOWN-REGULATION; DROSOPHILA PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN DISULFIDE-ISOMERASES; PROTEINS; PROTEOMICS; PROTO-ONCOGENE PROTEINS P21(RAS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTION FACTORS; UP-REGULATION; VIMENTIN; YOUNG ADULT;

EID: 77951711649     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01010.x     Document Type: Article

References (49)

1. Moncada S, Palmer R M, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
2. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. The ageing endothelium, cardiovascular risk and disease in man. Exp Physiol 2009, 94:317-321.
3. Gates P E, Strain W D, Shore A C. Human endothelial function and microvascular ageing. Exp Physiol 2009, 94:311-316.
4. McCormick A, Campisi J. Cellular aging and senescence. Curr Opin Cell Biol 1991, 3:230-234.
5. Serrano M, Lin A W, McCurrach M E, Beach D, Lowe S W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
6. Zhu J, Woods D, McMahon M, Bishop J M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998, 12:2997-3007.
7. Tyner S D, Venkatachalam S, Choi J. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415:45-53.
8. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
9. Gourlay C W, Ayscough K R. The actin cytoskeleton in ageing and apoptosis. FEMS Yeast Res 2005, 5:1193-1198.
10. Ivetic A, Ridley A J. Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology 2004, 112:165-176.
11. Zeiher A M, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993, 92:652-662.
12. Boraldi F, Bini L, Liberatori S. Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages. Proteomics 2003, 3:917-929.
13. Eman M R, Regan-Klapisz E, Pinkse M W. Protein expression dynamics during replicative senescence of endothelial cells studied by 2-D difference in-gel electrophoresis. Electrophoresis 2006, 27:1669-1682.
14. Chakravarti B, Seshi B, Ratanaprayul W. Proteome profiling of aging in mouse models: differential expression of proteins involved in metabolism, transport, and stress response in kidney. Proteomics 2009, 9:580-597.
15. Chang M W, Grillari J, Mayrhofer C. Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp Cell Res 2005, 309:121-136.
16. Poggioli S, Bakala H, Friguet B. Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins. Exp Gerontol 2002, 37:1207-1215.
17. Petzelbauer P, Bender J R, Wilson J, Pober J S. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993, 151:5062-5072.
18. Garcia G G, Miller R A. Age-related defects in CD4 + T cell activation reversed by glycoprotein endopeptidase. Eur J Immunol 2003, 33:3464-3472.
19. Garcia G G, Sadighi Akha A A, Miller R A. Age-related defects in moesin/ezrin cytoskeletal signals in mouse CD4 T cells. J Immunol 2007, 179:6403-6409.
20. Basta G, Schmidt A M, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004, 63:582-592.
21. Peppa M, Uribarri J, Vlassara H. Aging and glycoxidant stress. Hormones (Athens) 2008, 7:123-132.
22. Cines D B, Pollak E S, Buck C A. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
23. Choi B K, Cho Y M, Bae S H, Zoubaulis C C, Paik Y K. Single-step perfusion chromatography with a throughput potential for enhanced peptide detection by matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2003, 3:1955-1961.
24. Oender K, Trost A, Lanschuetzer C. Cytokeratin-related loss of cellular integrity is not a major driving force of human intrinsic skin aging. Mech Ageing Dev 2008, 129:563-571.
25. Franklin-Tong V E, Gourlay C W. A role for actin in regulating apoptosis/programmed cell death: evidence spanning yeast, plants and animals. Biochem J 2008, 413:389-404.
26. Gourlay C W, Ayscough K R. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005, 6:583-589.
27. Saintigny G, Bernard F X, Juchaux F, Pedretti N, Mahe C. Reduced expression of the adhesion protein tensin1 in cultured human dermal fibroblasts affects collagen gel contraction. Exp Dermatol 2008, 17:788-789.
28. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994, 63:345-382.
29. Colucci-Guyon E, Portier M M, Dunia I, Paulin D, Pournin S, Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994, 79:679-694.
30. Terzi F, Henrion D, Colucci-Guyon E. Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance. J Clin Invest 1997, 100:1520-1528.
31. Nishio K, Inoue A. Senescence-associated alterations of cytoskeleton: extraordinary production of vimentin that anchors cytoplasmic p53 in senescent human fibroblasts. Histochem Cell Biol 2005, 123:263-273.
32. Kueper T, Grune T, Prahl S. Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. J Biol Chem 2007, 282:23427-23436.
33. Foger N, Rangell L, Danilenko D M, Chan A C. Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. Science 2006, 313:839-842.
34. Shiow L R, Roadcap D W, Paris K. The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Nat Immunol 2008, 9:1307-1315.
35. Humphries C L, Balcer H I, D'Agostino J L. Direct regulation of Arp2/3 complex activity and function by the actin binding protein coronin. J Cell Biol 2002, 159:993-1004.
36. Chua B T, Volbracht C, Tan K O, Li R, Yu V C, Li P. Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol 2003, 5:1083-1089.
37. Cai L, Makhov A M, Bear J E. F-actin binding is essential for coronin 1B function in vivo. J Cell Sci 2007, 120:1779-1790.
38. Witke W, Li W, Kwiatkowski D J, Southwick F S. Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol 2001, 154:775-784.
39. Zhang R, Zhou L, Li Q, Liu J, Yao W, Wan H. Upregulation of two actin associated proteins prompts pulmonary artery smooth muscle cell migration under hypoxia. Am J Respir Cell Mol Biol 2009, 41:467-475.
40. Watari A, Takaki K, Higashiyama S. Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG. Oncogene 2006, 25:7373-7380.
41. Ho J, Bretscher A. Ras regulates the polarity of the yeast actin cytoskeleton through the stress response pathway. Mol Biol Cell 2001, 12:1541-1555.
42. Gourlay C W, Ayscough K R. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J Cell Sci 2005, 118:2119-2132.
43. Masuelli L, Ettenberg S, Vasaturo F, Vestergaard-Sykes K, Cutler M L. The ras suppressor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression. Cell Growth Differ 1999, 10:555-564.
44. Dougherty G W, Jose C, Gimona M, Cutler M L. The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells. Eur J Cell Biol 2008, 87:721-734.
45. Chunduru S, Kawami H, Gullick R, Monacci W J, Dougherty G, Cutler M L. Identification of an alternatively spliced RNA for the Ras suppressor RSU-1 in human gliomas. J Neurooncol 2002, 60:201-211.
46. Sullivan D C, Huminiecki L, Moore J W. EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem 2003, 278:47079-47088.
47. Altschmied J, Haendeler J. Thioredoxin-1 and endothelial cell aging: Role in cardiovascular diseases. Antioxid Redox Signal 2009, Epub
48. Hoffmann J, Haendeler J, Aicher A. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001, 89:709-715.
49. Asai K, Kudej R K, Shen Y T. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 2000, 20:1493-1499.